Directional Hemispherical Reflectance in the Analysis of Expired and Unexpired Tablets Containing Nifuroxazide—The Results of a Pilot Study †
Abstract
1. Introduction
2. Methods
3. Results and Discussion
Assessment of Directional Reflectance
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Bott, R.F.; Oliveira, W.P. Storage conditions for stability testing of pharmaceuticals in hot and humid regions. Drug Dev. Ind. Pharm. 2007, 33, 393–401. [Google Scholar] [CrossRef] [PubMed]
- Han, X.; Cheng, F.J.; Di, B.; Xu, H.; Song, M.; Hang, T.J.; Lu, Y.T. Identification and characterization of new impurities in zopiclone tablets by LC-QTOF-MS. J. Pharm. Biomed. Anal. 2021, 199, 114056. [Google Scholar] [CrossRef] [PubMed]
- Odani, N.; Mohan, S.; Kato, E.; Feng, H.; Li, Y.; Hossain, M.N.; Drennen, J.K.; Anderson, C.A. Determining the effect of photodegradation on film coated nifedipine tablets with terahertz based coating thickness measurements. Eur. J. Pharm. Biopharm. 2019, 145, 35–41. [Google Scholar] [CrossRef] [PubMed]
- Yamashita, S.; Iguchi, K.; Noguchi, Y.; Sakai, C.; Yokoyama, S.; Ino, Y.; Hayashi, H.; Teramachi, H.; Sako, M.; Sugiyama, T. Color change in Perlodel® tablets induced by LED lighting—Photolysis of bromocriptine mesylate. Pharmazie 2019, 74, 286–289. [Google Scholar] [PubMed]
- Thakral, N.K.; Yamada, H.; Stephenson, G.A.; Suryanarayanan, R. Spatial Distribution of Trehalose Dihydrate Crystallization in Tablets by X-ray Diffractometry. Mol. Pharm. 2015, 12, 3766–3775. [Google Scholar] [CrossRef] [PubMed]
- Vanhoof, R.; Hubrechts, J.M.; Roebben, E.; Nyssen, H.J.; Nulens, E.; Leger, J.; De Schepper, N. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms. Infection 1986, 14, 294–298. [Google Scholar] [CrossRef]
- Bailly, C. Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment. Drug Discov. Today 2019, 24, 1930–1936. [Google Scholar] [CrossRef]
- El-Sherbiny, M.; El-Sayed, R.M.; Helal, M.A.; Ibrahiem, A.T.; Elmahdi, H.S.; Eladl, M.A.; Bilay, S.E.; Alshahrani, A.M.; Tawfik, M.K.; Hamed, Z.E.; et al. Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling. Molecules 2021, 13, 6858. [Google Scholar] [CrossRef] [PubMed]
- Liu, J.Y.; Zhang, Y.C.; Xie, R.R.; Song, L.N.; Yang, W.L.; Xin, Z.; Cao, X.; Yang, J.K. Nifuroxazide improves insulin secretion and attenuates high glucose-induced inflammation and apoptosis in INS-1 cells. Eur. J. Pharmacol. 2021, 15, 174042. [Google Scholar] [CrossRef] [PubMed]
- Zhu, Y.; Ye, T.; Yu, X.; Lei, Q.; Yang, F.; Xia, Y.; Song, X.; Liu, L.; Deng, H.; Gao, T.; et al. Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma. Sci. Rep. 2016, 6, 20253. [Google Scholar] [CrossRef] [PubMed]
- Zhao, T.; Jia, H.; Cheng, Q.; Xiao, Y.; Li, M.; Ren, W.; Li, C.; Feng, Y.; Feng, Z.; Wang, H.; et al. Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma. Oncol. Rep. 2017, 37, 3405–3414. [Google Scholar] [CrossRef] [PubMed]
- Said, E.; Zaitone, S.A.; Eldosoky, M.; Elsherbiny, N.M. Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats. Chem. Biol. Interact. 2018, 1, 111–120. [Google Scholar] [CrossRef] [PubMed]
- Jia, H.; Zhao, T.; Ji, Y.; Jia, X.; Ren, W.; Li, C.; Li, M.; Xiao, Y.; Wang, H.; Xu, K. Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Cell Death Dis. 2016, 1, e2507. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Wilczyński, S.; Koprowski, R.; Błońska-Fajfrowska, B. Directional reflectance analysis for identifying counterfeit drugs: Preliminary study. J. Pharm. Biomed. Anal. 2016, 30, 341–346. [Google Scholar] [CrossRef] [PubMed]
- Wilczyński, S.; Koprowski, R.; Marmion, M.; Duda, P.; Błońska-Fajfrowska, B. The use of hyperspectral imaging in the VNIR (400–1000 nm) and SWIR range (1000–2500 nm) for detecting counterfeit drugs with identical API composition. Talanta 2016, 160, 1–8. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sarecka-Hujar, B.; Szulc-Musioł, B. Directional Hemispherical Reflectance in the Analysis of Expired and Unexpired Tablets Containing Nifuroxazide—The Results of a Pilot Study. Eng. Proc. 2022, 19, 39. https://doi.org/10.3390/ECP2022-12616
Sarecka-Hujar B, Szulc-Musioł B. Directional Hemispherical Reflectance in the Analysis of Expired and Unexpired Tablets Containing Nifuroxazide—The Results of a Pilot Study. Engineering Proceedings. 2022; 19(1):39. https://doi.org/10.3390/ECP2022-12616
Chicago/Turabian StyleSarecka-Hujar, Beata, and Beata Szulc-Musioł. 2022. "Directional Hemispherical Reflectance in the Analysis of Expired and Unexpired Tablets Containing Nifuroxazide—The Results of a Pilot Study" Engineering Proceedings 19, no. 1: 39. https://doi.org/10.3390/ECP2022-12616
APA StyleSarecka-Hujar, B., & Szulc-Musioł, B. (2022). Directional Hemispherical Reflectance in the Analysis of Expired and Unexpired Tablets Containing Nifuroxazide—The Results of a Pilot Study. Engineering Proceedings, 19(1), 39. https://doi.org/10.3390/ECP2022-12616